miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines

Acta Biochimica et Biophysica Sinica

Volumn 43, Issue 3, 2011, Pages 217-225

  Chai, Huijuan ^a   Liu, Min ^a   Tian, Ruiqing ^a   Li, Xin ^a   Tang, Hua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

BNIP2; chemotherapeutic resistance; colorectal adenocarcinoma; microRNA 20a

Indexed keywords

ANTINEOPLASTIC AGENT; BNIP2 PROTEIN, HUMAN; CARRIER PROTEIN; FLUOROURACIL; MICRORNA; MIRN20 MICRORNA, HUMAN; OXALIPLATIN; PLATINUM COMPLEX; TENIPOSIDE;

ADENOCARCINOMA; ARTICLE; COLORECTAL TUMOR; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CARRIER PROTEINS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; ORGANOPLATINUM COMPOUNDS; TENIPOSIDE;

EID: 79951881614     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmq125     Document Type: Article

References (37)

1. Longley DB, Allen WL and Johnston PG. Drug resistance, predictive markers and pharmacogenomics in colorectal cancer. Biochim Biophys Acta 2006, 1766: 184-196.
2. Fojo T. Multiple paths to a drug resistance phenotype: mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and miRNAs. Drug Resist Update 2007, 10: 59-67. (Pubitemid 46656478)
3. Allen WL, Coyle VM and Johnston PG. Predicting the outcome of chemotherapy for colorectal cancer. Curr Opin Pharmacol 2006, 6: 332-336.
4. Blower PE, Chung JH, Verducci JS, Lin S, Park JK, Dai Z and Liu CG, et al. MiRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 2008, 7: 1-9.
5. Calin GA and Croce CM. MiRNA signatures in human cancers. Nat Rev Cancer 2006, 6: 857-866.
6. Bartel DP. MiRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116: 281-297.
7. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S and Powers S, et al. A miRNA polycistron as a potential human oncogene. Nature 2005, 435: 828-833. (Pubitemid 40839734)
8. Chen CZ, Li L, Lodish HF and Bartel DP. MiRNAs modulate hematopoietic lineage differentiation. Science 2004, 303: 83-86. (Pubitemid 38055775)
9. Chan JA, Krichevsky AM and Kosik KS. MiRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005, 65: 6029-6033. (Pubitemid 40994386)
10. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M and Wojcik SE, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005, 102: 13944-13949. (Pubitemid 41377683)
11. Slabý O, Krekác D, Hrstka R, Svoboda M and Vyzula R. Involvement of miRNAs in cancer biology and possibilities of their application to diagnostic and predictive oncology. Cas Lek Cesk 2008, 147: 25-31.
12. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D and Sweet-Cordero A, et al. miRNA expression profiles classify human cancers. Nature, 2005, 435: 834-838. (Pubitemid 40839735)
13. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N and Yuen ST, et al. MiRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299: 425-436. (Pubitemid 351185951)
14. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, Mendell JT and Jiang J, et al. Involvement of human miRNAs in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006, 130: 2113-2129. (Pubitemid 43816961)
15. Mishra PJ, Humeniuk R, Mishra PJ, Longo-Sorbello GS, Banerjee D and Bertino JR. A miR-24 miRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci USA 2007, 104: 13513-13518. (Pubitemid 47293976)
16. Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF and Pogribny IP. Involvement of miRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Mol Cancer Ther 2008, 7: 2152-2159.
17. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S and Hong L, et al. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008, 123: 372-379. (Pubitemid 351842022)
18. Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA, Jr, Sjoblom T and Barad O, et al. The colorectal miRNAome. Proc Natl Acad Sci USA 2006, 103: 3687-3692.
19. Bandrés E, Cubedo E, Agirre X, Malumbres R, Zárate R, Ramirez N and Abajo A, et al. Identification by real-time PCR of 13 mature miRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006, 5: 29.
20. Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP and James RJ. Reduced accumulation of specific miRNAs in colorectal neoplasia. Mol Cancer Res 2003, 1: 882-891. (Pubitemid 37288707)
21. Leibovitz A, Stinson JC, McCombs WB, III, McCoy CE, Mazur KC and Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res 1976, 36: 4562-4569.
22. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT and Barbisin M, et al. Real-time quantification of miRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33: e179.
23. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2244C(T) method. Methods 2001, 25: 402-408. (Pubitemid 34164012)
24. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S and Yoshida Y, et al. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 2004, 64: 3087-3095. (Pubitemid 38581408)
25. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT. c-Myc-regulated miRNAs modulate E2F1 expression. Nature 2005, 435: 839-843. (Pubitemid 40839736)
26. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F and Ferbeyre G, et al. An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 2007, 282: 2135-2143. (Pubitemid 47076740)
27. Davis S, Lollo B, Freier S and Esau C. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res, 2006, 34: 2294-2304. (Pubitemid 43985667)
28. Belcredito S, Vegeto E, Brusadelli A, Ghisletti S, Mussi P, Ciana P and Maggi A. Estrogen neuroprotection: the involvement of the Bcl-2 binding protein BNIP2. Brain Res Rev 2001, 37: 335-342. (Pubitemid 34023594)
29. Raguz S and Yagüe E. Resistance to chemotherapy: new treatments and novel insights into an old problem. Br J Cancer 2008, 99: 387-391.
30. He L and Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004, 5: 522-531. (Pubitemid 38868508)
31. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP and Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007, 27: 91-105. (Pubitemid 46991392)
32. Didiano D and Hobert O. Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions. Nat Struct Mol Biol 2006, 13: 849-851. (Pubitemid 44338780)
33. Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B and D'Sa-Eipper C, et al. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell 1994, 79: 341-351. (Pubitemid 24324923)
34. Aouacheria A, Brunet F and Gouy M. Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators. Mol Biol Evol 2005, 22: 2395-2416.
35. Bouillet P and Strasser A. BH3-only proteins-evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci 2002, 115: 1567-1574. (Pubitemid 34520586)
36. Kim R. Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 2005, 103: 1551-1560. (Pubitemid 40490015)
37. Valencia CA, Cotten SW and Liu R. Cleavage of BNIP-2 and BNIP-XL by caspases. Biochem Biophys Res Commun 2007, 364: 495-501. (Pubitemid 350026494)